NCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinoma
about
Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genesNCOA5, a molecular link between type 2 diabetes and liver cancer.Prediabetes and the risk of cancer: a meta-analysis.An LXR-NCOA5 gene regulatory complex directs inflammatory crosstalk-dependent repression of macrophage cholesterol efflux.Antiangiogenic effects of oridonin.NCOA5, IL-6, type 2 diabetes, and HCC: The deadly quartet.Glucose intolerance and hepatocellular carcinoma: recent findings for old diseases.Prediabetes and associated disorders.A single non-synonymous NCOA5 variation in type 2 diabetic patients with hepatocellular carcinoma impairs the function of NCOA5 in cell cycle regulation.Insights into the relationships between diabetes, prediabetes, and cancer.Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma.Clinical significance of NCOA5 gene rs2903908 polymorphism in Behçet's disease.NCOA5 promotes proliferation, migration and invasion of colorectal cancer cells via activation of PI3K/AKT pathway.A novel tumor suppressor gene NCOA5 is correlated with progression in papillary thyroid carcinoma.Association between expression of nuclear receptor co-activator 5 protein and prognosis in postoperative patients with osteosarcoma.Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice.
P2860
Q26772317-DEE422B3-1B0F-4C46-BB18-D1C776531369Q33814414-0A40B109-EDF4-4165-B93C-F4A53213829BQ35246551-87EFC1AA-38BD-4B56-B285-86BAB6767FAAQ35590401-4A3E1372-283E-4510-A09D-AFF728E07E82Q36334914-0AA97672-F58C-4E8A-8147-21825716A5E4Q37627381-B6EDC954-1294-4351-A4CE-643DC0CFAE60Q37722922-8F72A1A6-52BB-48D9-82AA-A7CDF454613BQ38257985-E9B8140C-D9B1-42F2-9721-0E8C8E0D57B7Q38991357-4501BF50-FFEE-4759-884E-C90AA476AA97Q39063925-64D7073B-3384-4F39-A514-2A1C31F13D41Q39817084-38FB159D-5D32-4B84-A516-548B8888FE66Q40996100-16852836-C69E-4377-AEE3-70BC848894C2Q47123866-CD8B4270-E761-4446-8A89-F5F4512D92E0Q49387480-90085666-18CE-42A4-833E-55414406E213Q50053701-B6BC7AC3-FF0E-4885-9B1A-D0ADD15754E0Q51734662-91298C3A-CFDD-4924-B626-8EC5F1891258
P2860
NCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinoma
description
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2013
@ast
im Dezember 2013 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2013/12/09)
@sk
vědecký článek publikovaný v roce 2013
@cs
wetenschappelijk artikel (gepubliceerd op 2013/12/09)
@nl
наукова стаття, опублікована в грудні 2013
@uk
مقالة علمية (نشرت في 9-12-2013)
@ar
name
NCOA5 haploinsufficiency resul ...... quent hepatocellular carcinoma
@ast
NCOA5 haploinsufficiency resul ...... quent hepatocellular carcinoma
@en
NCOA5 haploinsufficiency resul ...... quent hepatocellular carcinoma
@nl
type
label
NCOA5 haploinsufficiency resul ...... quent hepatocellular carcinoma
@ast
NCOA5 haploinsufficiency resul ...... quent hepatocellular carcinoma
@en
NCOA5 haploinsufficiency resul ...... quent hepatocellular carcinoma
@nl
prefLabel
NCOA5 haploinsufficiency resul ...... quent hepatocellular carcinoma
@ast
NCOA5 haploinsufficiency resul ...... quent hepatocellular carcinoma
@en
NCOA5 haploinsufficiency resul ...... quent hepatocellular carcinoma
@nl
P2093
P2860
P921
P3181
P1433
P1476
NCOA5 haploinsufficiency resul ...... quent hepatocellular carcinoma
@en
P2093
Chin-Lee Wu
Fengsheng Chen
Mark Williams
Rongcheng Luo
Shenglan Gao
Zakiya Kelley
P2860
P304
P3181
P356
10.1016/J.CCR.2013.11.005
P50
P577
2013-12-09T00:00:00Z